Love R. By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer. Arch Breast Cancer [Internet]. 2021 Jan. 28 [cited 2025 Jun. 3];:8-13. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/337